GGrantIndex
← Search

Implementation Strategies Addressing Caribbean Stigma to Improve the Woman-to- Woman Cervical Cancer Prevention Intervention

$235,100P30FY2023CANIH

Beckman Research Institute/City Of Hope, Duarte CA

Investigators

Linked publications, trials & patents

Trial NCT07664670Trial NCT07664579Trial NCT07650656Trial NCT07628894Trial NCT07619599Trial NCT07612085Trial NCT07611370Trial NCT07608627Trial NCT07608458Trial NCT07608445Trial NCT07595874Trial NCT07590583Trial NCT07583810Trial NCT07583303Trial NCT07582172Trial NCT07582159Trial NCT07578077Trial NCT07578025Trial NCT07544992Trial NCT07365306Trial NCT07363408Trial NCT07293403Trial NCT07288034Trial NCT07278856Trial NCT07275216Trial NCT07271355Trial NCT07235501Trial NCT07226544Trial NCT07226102Trial NCT07225855Trial NCT07225738Trial NCT07220447Trial NCT07219147Trial NCT07218913Trial NCT07218718Trial NCT07218692Trial NCT07218510Trial NCT07210086Trial NCT07202247Trial NCT07184294Trial NCT07136493Trial NCT07133997Trial NCT07128680Trial NCT07126301Trial NCT07125729Trial NCT07042438Trial NCT07040982Trial NCT07037004Trial NCT07025564Trial NCT07025538Trial NCT07020533Trial NCT07003100Trial NCT06996119Trial NCT06985784Trial NCT06954831Trial NCT06922604Trial NCT06918431Trial NCT06910761Trial NCT06860815Trial NCT06859008Trial NCT06834126Trial NCT06815029Trial NCT06815003Trial NCT06780787Trial NCT06763341Trial NCT06763328Trial NCT06735690Trial NCT06735664Trial NCT06731894Trial NCT06675136Trial NCT06675123Trial NCT06672224Trial NCT06626256Trial NCT06625619Trial NCT06581211Trial NCT06580015Trial NCT06575725Trial NCT06575686Trial NCT06575296Trial NCT06572631Trial NCT06572618Trial NCT06572605Trial NCT06549478Trial NCT06543381Trial NCT06538389Trial NCT06500377Trial NCT06498973Trial NCT06454409Trial NCT06454383Trial NCT06453044Trial NCT06447987Trial NCT06440850Trial NCT06408220Trial NCT06399419Trial NCT06328621Trial NCT06287944Trial NCT06260033Trial NCT06249282Trial NCT06196008Trial NCT06195891

Abstract

PROJECT SUMMARY This application is being submitted in response to the Notice of Special Interest (NOSI) identified as “NOT-CA- 23-036”. The overall objective of the proposed study is to build upon our program of Caribbean stigma research relevant to cancer prevention. Our preliminary study shows that in the Caribbean, stigma bars preventive care including cervical cancer screening and HPV vaccination. In response, to address cancer stigma for the Caribbean contexts, we will employ implementation science approaches to improve the evidenced Woman to Woman intervention (W2W) to reduce stigma and increase cancer prevention. Rooted in implementation science, we will be guided by diverse stakeholder perspectives, and the preliminary results of our recent population-based Caribbean stigma survey (CCSS, N=2233) to enhance the W2W intervention by including a stigma reduction component to the curriculum. We will leverage our vast African Caribbean Cancer Consortium (AC3) of community partners including Lay Health Advisors and clinicians to inform and guide the improvements to W2W using implementation science approaches to enhance the curriculum and strategies of W2W to reduce cancer stigma, and increase cervical cancer screening and HPV vaccination. To accomplish this objective, we propose the following specific aims: Aim 1: Informed by our Caribbean Cancer and Stigma Study survey (N= 2233) and qualitative results, using the Evidenced Based Process (EBP) modification strategies to improve the current W2W intervention with a stigma reduction curriculum. Aim 2: Engage multi-stakeholder perspectives using community health workers focus groups and clinician interviews to further refine the improved Aim 1 W2W intervention. We will incorporate cultural stigma consideration and reduction domain and content derived from the clinician and community health workers; address HPV vaccination improvements, and enhance implementation strategy to create the enhanced W2W_End Stigma-End Cervical Cancer intervention. Multi-sectoral stakeholders will ensure W2W_End Stigma-End Cervical Cancer intervention’s cultural congruence to reduce cancer stigma as a barrier to cervical cancer screening and HPV vaccination. This implementation science research will be the first to provide novel and requisite stakeholder results to inform co- created (community advocate, clinician, and researcher) stigma reduction curriculum and communication strategies for optimal provider and patient activation for increased uptake of cervical cancer screening and HPV vaccination. Therefore, our study findings will improve the evidenced W2W intervention creating the W2W_End Stigma-End Cervical Cancer to eliminate stigma as a barrier to cervical cancer screening and HPV vaccination, for near future Caribbean intervention dissemination.

View original record on NIH RePORTER →